Clinical trial
Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes on Corneal Transplant Success and Endothelial Cell Loss
NCT05134480 is registered in ClinicalTrials.gov with Case Western Reserve University as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Diabetes Endothelial Keratoplasty Study (DEKS): Impact of Diabetes on Corneal Transplant Success and Endothelial Cell Loss
- Lead sponsor
- Case Western Reserve University
- Phase
- Not applicable
- Overall status
- Completed
- Start date
- January 21, 2022
- Completion date
- September 15, 2025
- Enrollment
- 1,097 (actual)
- Sites
- 2
Conditions
As the registry lists them; a condition with its own page is linked.
corneal endothelial decompensation, fuchs' endothelial dystrophy